arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

ProMIS Neurosciences Inc.

PMN

$13.50 ▲ +0.02 (+0.15%) at close

6 Visible periods

22 Metrics

Absolute Benchmarks

Price Chart

Health

Weak

Neutral Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, ProMIS Neurosciences Inc. shows solid but mixed fundamentals, with Return on Invested Capital holding up well. Watch FCF / Net Income against typical quality thresholds. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $23.7M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 2521.2% ↗

FCF / Share $-16.01 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 6, 2026.

6-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-39.72M

↓ -1529.3% —

FCF / Share Free cash flow per share

$-16.01

↑ +39.0% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

Return on Invested CapitalReturn on Invested Capital of 2521.2% is excellent on an absolute basis (target > 10%)

warning

Bearish Risks

FCF / Net IncomeFCF / Net Income of 0.71x is caution on an absolute basis (target > 1x)

Health Breakdown

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
EPS Growth YoY (%)	N/M	N/M	55.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-42.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	N/M	N/M	26.9% Excellent Excellent Year-over-year change in net income	-84.5% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	39.0% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-18.9% Weak ↓ Weak Declining Year-over-year change in free cash flow	61.2% Excellent Excellent Year-over-year change in free cash flow	-41.1% Weak Weak Year-over-year change in free cash flow	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
FCF / Net Income (x)	0.71x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-9.78x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	2521.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-80.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-300.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	1370.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-68.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-437.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-89.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-104.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-337.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-46.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	—	16.9% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+12%)	—	—	-173.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1253%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Debt to Equity (x)	—	—	—	—	0.69x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+15%)	—
Interest Coverage (x)	—	-219.18x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-70.82x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-82.89x Weak Weak Operating income divided by interest expense Optimal: > 5x	-19.92x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-6.12M	$-13.29M	$-12.60M	$-5.88M	$-13.04M	—
Debt / EBITDA (x)	—	—	—	—	-0.47x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Basic EPS, GAAP (USD)	$-22.61	$2.75	$-26.75	$-60.25	$-42.25	—
Free Cash Flow per Share (USD)	$-16.01	$-26.22	$-22.05	$-56.77	$-40.24	—
Book Value per Share (USD)	$-0.58	$12.61	$4.97	$-3.93	$19.67	—
Tangible Book Value per Share (USD)	$-0.58	$12.61	$4.97	$-3.99	$19.57	—
Basic Weighted Avg Shares (shares)	1.76M	1.04M	491,708	300,104	231,425	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$-1.23M	$16.69M	$4.27M	$490.44K	$16.79M	—
LT Debt (USD)	—	—	—	—	$3.91M	—
Total Equity (USD)	$-1.26M	$16.49M	$3.75M	$-1.35M	$5.66M	$-796.66K

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Depreciation Expense (USD)	—	—	$321.00	$6.14K	$40.58K	—
Net Income, GAAP (USD)	$-39.72M	$2.78M	$-13.21M	$-18.06M	$-9.79M	—
Operating Cash Flow (USD)	$-28.12M	$-27.18M	$-10.84M	$-17.03M	$-9.31M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 22 quarters

ProMIS Neurosciences Inc.

Analytical Summary

6-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare PMN with peers